For 9 of the 12 severe COVID-19 patients who were positive for anti-IFNα2 IgG autoantibodies, we had multiple plasma samples that were collected around the time of ICU admission, ICU discharge, or at hospital discharge. The gene discussed is IFNA2; the disease is COVID-19.